Flow characterization of a pharmaceutical excipient using the shear cell method

The powders used in the production of solid dosage forms must have ability to flow that allows their industrial processing. Although this property has been studied for most of the powders, in this study non-expected flow behaviors were observed for the model excipient used, Microcrystalline Cellulos...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutical development and technology Vol. 25; no. 2; p. 237
Main Authors Salústio, Paulo José, Inácio, Cláudia, Nunes, Telmo, Sousa E Silva, José Paulo, Costa, Paulo Cardoso
Format Journal Article
LanguageEnglish
Published England 07.02.2020
Subjects
Online AccessGet more information

Cover

Loading…
Abstract The powders used in the production of solid dosage forms must have ability to flow that allows their industrial processing. Although this property has been studied for most of the powders, in this study non-expected flow behaviors were observed for the model excipient used, Microcrystalline Cellulose (MCC). Several fractions with different sizes were fractioned by sieving of the model excipient and its flow behaviors were analyzed by different methods. The shear cell results showed an increase of the flowability index ( ) with the increase of the particle size and consolidation stress. Some related information has been referenced in the literature, however, in this work it was shown for different size fractions that the decreased above a certain consolidation stress value (2000-4000 N/m ). The explanation of this phenomenon is based on the increase of cohesion. Furthermore, it was also observed that the fractions with sizes between 125-180 µm present a higher than bulk powder (F ) with similar percentile (D 50) indicating that this index is dependent on the size of the particles and also on its size distribution range. Thus, it can be affirmed that more homogeneous samples in size and with a narrower distribution present a better .
AbstractList The powders used in the production of solid dosage forms must have ability to flow that allows their industrial processing. Although this property has been studied for most of the powders, in this study non-expected flow behaviors were observed for the model excipient used, Microcrystalline Cellulose (MCC). Several fractions with different sizes were fractioned by sieving of the model excipient and its flow behaviors were analyzed by different methods. The shear cell results showed an increase of the flowability index ( ) with the increase of the particle size and consolidation stress. Some related information has been referenced in the literature, however, in this work it was shown for different size fractions that the decreased above a certain consolidation stress value (2000-4000 N/m ). The explanation of this phenomenon is based on the increase of cohesion. Furthermore, it was also observed that the fractions with sizes between 125-180 µm present a higher than bulk powder (F ) with similar percentile (D 50) indicating that this index is dependent on the size of the particles and also on its size distribution range. Thus, it can be affirmed that more homogeneous samples in size and with a narrower distribution present a better .
Author Salústio, Paulo José
Costa, Paulo Cardoso
Inácio, Cláudia
Nunes, Telmo
Sousa E Silva, José Paulo
Author_xml – sequence: 1
  givenname: Paulo José
  surname: Salústio
  fullname: Salústio, Paulo José
  organization: Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), University of Lisbon. Av. Prof. Gama Pinto, Lisbon, Portugal
– sequence: 2
  givenname: Cláudia
  surname: Inácio
  fullname: Inácio, Cláudia
  organization: Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), University of Lisbon. Av. Prof. Gama Pinto, Lisbon, Portugal
– sequence: 3
  givenname: Telmo
  surname: Nunes
  fullname: Nunes, Telmo
  organization: Faculty of Sciences, University of Lisbon, Lisbon, Portugal
– sequence: 4
  givenname: José Paulo
  surname: Sousa E Silva
  fullname: Sousa E Silva, José Paulo
  organization: UCIBIO/REQUIMTE, MedTech-Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
– sequence: 5
  givenname: Paulo Cardoso
  surname: Costa
  fullname: Costa, Paulo Cardoso
  organization: UCIBIO/REQUIMTE, MedTech-Laboratory of Pharmaceutical Technology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Porto, Portugal
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31718375$$D View this record in MEDLINE/PubMed
BookMark eNo1j9tKxDAURYMozkU_QckPtObSNMmjDI4KA_My78NJcmojvdGmePl6C-rL3rBgL9gbctn1HRJyx1nOmWEPS0hdKJYLxm3OS2NkYS7ImjOrM2tKvSKbaXpnjBvL1DVZSa75MlFrctw3_Qf1NYzgE47xG1LsO9pXFOiw0BY8zil6aCh--jhE7BKdp9i90VQjnWqEkXpsGtpiqvtwQ64qaCa8_estOe2fTruX7HB8ft09HjIvrUhZJdGWwilnnNVBCvAeLJRMa47COQjcucpZkF5IVVZBMl0EAQa4Ujo4sSX3v9phdi2G8zDGFsav8_8x8QPF8FJl
CitedBy_id crossref_primary_10_1080_03639045_2021_2004158
crossref_primary_10_1080_10837450_2020_1731531
crossref_primary_10_1007_s12247_020_09478_6
crossref_primary_10_3390_powders1040016
crossref_primary_10_2174_1573401318666220211101143
crossref_primary_10_1016_j_powtec_2023_119025
ContentType Journal Article
DBID NPM
DOI 10.1080/10837450.2019.1688348
DatabaseName PubMed
DatabaseTitle PubMed
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1097-9867
ExternalDocumentID 31718375
Genre Journal Article
GroupedDBID ---
00X
03L
0BK
0R~
123
29O
36B
4.4
53G
5VS
8V8
AACCU
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABCRQ
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ADCVX
ADRBQ
ADXPE
AECIN
AEMOZ
AENEX
AEOZL
AFAUU
AFKVX
AFQCT
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJEBJ
AJWEG
AJXHO
AKBVH
AKVCP
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AWYRJ
BABNJ
BLEHA
BOHLJ
BVLLS
CAG
CCCUG
COF
CS3
DEIEU
DKSSO
DLVIE
DTRLO
DU5
DZHFC
EBD
EBO
EBR
EBS
EBU
EHE
EJD
EMB
EMK
EMOBN
EPL
F5P
H13
HZ~
JFOCU
K1G
KRBQP
KWAYT
KYCEM
LJTGL
M44
M4Z
MK0
NPM
NUSFT
O9-
P2P
QRXOQ
RNANH
RVRKI
SV3
TBQAZ
TDBHL
TERGH
TFDNU
TFL
TFW
TH9
TUROJ
UHWXJ
V1S
~1N
ID FETCH-LOGICAL-c392t-f3e962b5b8b97d32acca9a60771e2bbad1bbfb9a3c2356fd3074d2a8a1557db2
IngestDate Wed Oct 16 00:47:31 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords flow index
shear cell
sieving
Flowing
excipient
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c392t-f3e962b5b8b97d32acca9a60771e2bbad1bbfb9a3c2356fd3074d2a8a1557db2
OpenAccessLink http://hdl.handle.net/10451/54099
PMID 31718375
ParticipantIDs pubmed_primary_31718375
PublicationCentury 2000
PublicationDate 2020-02-07
PublicationDateYYYYMMDD 2020-02-07
PublicationDate_xml – month: 02
  year: 2020
  text: 2020-02-07
  day: 07
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmaceutical development and technology
PublicationTitleAlternate Pharm Dev Technol
PublicationYear 2020
SSID ssj0018905
Score 2.2972546
Snippet The powders used in the production of solid dosage forms must have ability to flow that allows their industrial processing. Although this property has been...
SourceID pubmed
SourceType Index Database
StartPage 237
Title Flow characterization of a pharmaceutical excipient using the shear cell method
URI https://www.ncbi.nlm.nih.gov/pubmed/31718375
Volume 25
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb5wwELY2rVTlUvXdpmnlQ5ULIcUYjH1MokRRpW4jhUq5RTbY6kpkWWmX5vG38gc7xoZlN2nV9gILXgbEfIzH80TokySkhFk2CVMdFWFiOAsFi1Voi8PpTBKdtv1Tvo7Zyffky3l6PhrdDaKWmoXaK24fzCv5H67COeCrzZL9B872ROEE_Ab-whY4DNu_4vFxVV_Z1F1fcvm2V_9kMPuxYqvW18VkZlMfg2beJUjNbTPrwFrufR_poaJ6unp9uYwtcjGX9yzyZ7KyTveDfZAZdRdzWFsPg_PF9xictsekcP86rNxhU076CWLc-P4Bua4u6_4GdTOXwVFwNql-Su-8cKTdrYb2C1is2pBnN8dqJ3MjkYWCu64cnVB22dAefPFQwroaMfckvwuVhB3NkjSyMXtijzDOqSvkOUDD7LKFAyhOIM5c25Y_j64V5O6GNtBGxq1oHVsDkXdccRGlXaIYjz4_-Dyb6ElHY20x0yo1-TP01K9G8L6D1nM00tMXaMfz_mYX58vsvPku3sGny0LnNy_RN4s_vI4_XBss8Sr-cI8_3OIPA_5wiz9s8Ycd_l6h_PgoPzwJfYOOsAC1ehEaqu2HnSquRFbSWII4EJJFWUZ0rJQsiVJGCUmLmKbMlDCfJGUsuQQlNitV_Bo9mtZT_RZhWDVEpqAslZwkQMzSY8xQQZkmUWHeoTfuPV3MXBGWi-4Nbv125D3aXOJtGz028NXrD6BCLtTHlmm_AJC5bmg
link.rule.ids 783
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flow+characterization+of+a+pharmaceutical+excipient+using+the+shear+cell+method&rft.jtitle=Pharmaceutical+development+and+technology&rft.au=Sal%C3%BAstio%2C+Paulo+Jos%C3%A9&rft.au=In%C3%A1cio%2C+Cl%C3%A1udia&rft.au=Nunes%2C+Telmo&rft.au=Sousa+E+Silva%2C+Jos%C3%A9+Paulo&rft.date=2020-02-07&rft.eissn=1097-9867&rft.volume=25&rft.issue=2&rft.spage=237&rft_id=info:doi/10.1080%2F10837450.2019.1688348&rft_id=info%3Apmid%2F31718375&rft_id=info%3Apmid%2F31718375&rft.externalDocID=31718375